Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Gravesʼ orbitopathy (MINGO): A randomised, observer-masked, multicentre trial - Kahaly, G J; Riedl, M; König, J (Lancet Diabetes Endocrinol, 2018)
et al.